APA (7th ed.) Citation

Levey, A. I., Qiu, D., Zhao, L., Hu, W. T., Duong, D. M., Higginbotham, L., . . . Weinshenker, D. (2022). A phase II study repurposing atomoxetine for neuroprotection in mild cognitive impairment. Brain (London, England : 1878), 145(6), 1924-1938. https://doi.org/10.1093/brain/awab452

Chicago Style (17th ed.) Citation

Levey, Allan I., et al. "A Phase II Study Repurposing Atomoxetine for Neuroprotection in Mild Cognitive Impairment." Brain (London, England : 1878) 145, no. 6 (2022): 1924-1938. https://doi.org/10.1093/brain/awab452.

MLA (9th ed.) Citation

Levey, Allan I., et al. "A Phase II Study Repurposing Atomoxetine for Neuroprotection in Mild Cognitive Impairment." Brain (London, England : 1878), vol. 145, no. 6, 2022, pp. 1924-1938, https://doi.org/10.1093/brain/awab452.